Garczyk, S., Klotz, N., Szczepanski, S., Denecke, B., Antonopoulos, W., von Stillfried, S., . . . Dahl, E. (2017). Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway. Oncotarget.

Garczyk, Stefan, Natalie Klotz, Sabrina Szczepanski, Bernd Denecke, Wiebke Antonopoulos, Saskia von Stillfried, Ruth Knüchel, Michael Rose, and Edgar Dahl. "Oncogenic Features of Neuromedin U in Breast Cancer Are Associated With NMUR2 Expression Involving Crosstalk With Members of the WNT Signaling Pathway." Oncotarget 2017.

Garczyk, Stefan, et al. "Oncogenic Features of Neuromedin U in Breast Cancer Are Associated With NMUR2 Expression Involving Crosstalk With Members of the WNT Signaling Pathway." Oncotarget 2017.